Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-3.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -99.99% |
| Q3 2025 | 713774.30% |
| Q2 2025 | 4.14% |
| Q1 2025 | 7.38% |
| Q4 2024 | 4.34% |
| Q3 2024 | -9.13% |
| Q2 2024 | -26.87% |
| Q1 2024 | 22.44% |
| Q4 2023 | 2.78% |
| Q3 2023 | 2.35% |
| Q2 2023 | 9.12% |
| Q1 2023 | -0.04% |
| Q4 2022 | 190.64% |
| Q3 2022 | 4.17% |
| Q2 2022 | -53.98% |
| Q1 2022 | 1.98% |
| Q4 2021 | 88.33% |
| Q3 2021 | 1.92% |
| Q2 2021 | 2.72% |
| Q1 2021 | 0.73% |
| Q4 2020 | 28.30% |
| Q3 2020 | -0.64% |
| Q2 2020 | -52.09% |
| Q1 2020 | 26.64% |
| Q4 2019 | -2.35% |
| Q3 2019 | -0.20% |
| Q2 2019 | -8.50% |
| Q1 2019 | -8.73% |
| Q4 2018 | -19.68% |
| Q3 2018 | 2.17% |
| Q2 2018 | 0.62% |
| Q1 2018 | 26.14% |
| Q4 2017 | -6.52% |
| Q3 2017 | 8.43% |
| Q2 2017 | 37.43% |
| Q1 2017 | 12.61% |
| Q4 2016 | 25.71% |
| Q3 2016 | -5.48% |
| Q2 2016 | -37.07% |
| Q1 2016 | -5.24% |